Sanjeev Arora, MD, Director, Project Echo
Neil H. Segal, M.D., Ph.D. Assistant Attending Gastrointestinal Oncology Service and Immunotherapeutics Core Memorial Sloan-Kettering Cancer Center.
Inibitori delle proteasi di I generazione: sono una reale innovazione? - Gastrolearning®
Apha slides tfah hep b &c levi slides[1]
Drug pricing 04 oct14
Steatosis and hcv__as published
HepatitisC virus HCV Direct Acting Antivirals
Because Response to Interferon is Personal Genefron Personalized Medicine Diagnostic July 2013.
How to manage non responders Lawrence Serfaty Service d’Hépatologie, UMR S 893 Hôpital Saint-Antoine, UPMC, Paris Clinical case 1.
Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients Deirdre Sawinski MD, Kimberly A.
Hepatocellular Carcinoma: Progress at last Alan P. Venook, M.D. University of California, San Francisco.
What is New in HCV Genotype 4 ? Prof. Gamal Esmat Endemic Medicine and Hepatology, Cairo University Director of Viral Hepatitis Treatment Centers,Egypt.